Codexis (CDXS) Tax Provisions (2010 - 2026)

Codexis' (CDXS) quarterly Tax Provisions came in at $36000.0 in Q1 2026, up 227.27% year-on-year from $11000.0 in Q1 2025, and up 100.0% quarter-over-quarter from $18000.0 in Q4 2025.

Codexis (CDXS) Tax Provisions (2010 - 2026) Analysis & Trends

Codexis' Tax Provisions history runs 17 years deep, the most recent figure standing at $36000.0 for Q1 2026.

  • On a quarterly basis, Tax Provisions rose 227.27% year-over-year to $36000.0 in Q1 2026; TTM through Mar 2026 was $72000.0, a 111.76% increase from a year earlier, with the FY2025 full-year figure at $47000.0, up 38.24% from the prior year.
  • Tax Provisions rose to $36000.0 in Q1 2026 per CDXS's latest filing, from $18000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $151000.0 in Q4 2022 and bottomed at $3000.0 in Q4 2024.
  • The 5-year median for Tax Provisions is $10000.0 (2024), against an average of $27117.6.
  • Biggest YoY gain for Tax Provisions was 1250.0% in 2022; the steepest drop was 92.73% in 2022.
  • Year by year, Tax Provisions stood at $151000.0 in 2022, then plunged by 76.82% to $35000.0 in 2023, then sank by 91.43% to $3000.0 in 2024, then jumped by 500.0% to $18000.0 in 2025, then soared by 100.0% to $36000.0 in 2026.
  • Per Business Quant, the three latest CDXS Tax Provisions figures stand at $36000.0 (Q1 2026), $18000.0 (Q4 2025), and $8000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 125,146.46
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 31.86 Mn
4 NuCana 279.75 Bn 279.75 Bn - 188,883.60
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 221.50 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 179.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Codexis 180.63 Mn 115.49 Mn 13.18 Mn 36,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 36,000.00
Dec 31, 2025 18,000.00
Sep 30, 2025 8,000.00
Jun 30, 2025 10,000.00
Mar 31, 2025 11,000.00
Dec 31, 2024 3,000.00
Sep 30, 2024 10,000.00
Jun 30, 2024 10,000.00
Mar 31, 2024 10,000.00
Dec 31, 2023 35,000.00
Sep 30, 2023 9,000.00
Jun 30, 2023 9,000.00
Mar 31, 2023 16,000.00
Dec 31, 2022 151,000.00
Sep 30, 2022 8,000.00
Jun 30, 2022 108,000.00
Mar 31, 2022 9,000.00
Dec 31, 2021 68,000.00
Sep 30, 2021 110,000.00
Jun 30, 2021 8,000.00